HCM
HUTCHMED (China) Limited
Latest News for HCM
Hutchmed (China) Limited ($HCM) announced an update on their ongoing clinical study. Hutchmed has launched a new early stage trial for HMPL-A251 in......
In a report released on May 21, from UBS maintained a Buy rating on HUTCHMED (China) , with a price target of HK$34.10. The company’s shares closed......
Bernstein analyst Pujarini Ghosh maintained a Buy rating on Holcim yesterday. The company’s shares closed last Wednesday at CHF72.38. According to ......
HUTCHMED (China) ( ($HK:0013) ) has issued an announcement. HUTCHMED (China) Limited reported that all ordinary and special resolutions proposed at......
In a report released yesterday, Elodie Rall from J.P. Morgan maintained a Buy rating on Holcim. The company’s shares closed last Friday at CHF75.22......
Erste Group analyst Hans Engel maintained a Hold rating on Holcim yesterday. The company’s shares closed yesterday at CHF70.76. According to TipRan......
Erste Group analyst Hans Engel maintained a Hold rating on Holcim yesterday. The company’s shares closed yesterday at CHF70.76. According to TipRan......
UBS analyst Julian Radlinger maintained a Buy rating on Holcim today and set a price target of CHF93.00. According to TipRanks, Radlinger is a 2-st......
News data is sourced from MarketXLS API and updated regularly.
Showing 8 of 8 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HCM | $11.23 | -4.2% | 61.98K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get HUTCHMED (China) Limited Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW